Clinique Du Millenaire — Clinical Trial Site

9 Registered trials

6 Currently recruiting

Organisation

Clinique Du Millenaire

Location

Montpellier, France

Identifier

ORG-100044197

Address

280 Boulevard Penelope, 34000, France

Departments

Anesthesia and Intensive Care
Anesthesiology
Cardiologie
Cardiology
Cardiology department
Service de Cardiologie
Service de cardiologie - Rez-de-chaussée
Service de Cardiologie Interventionelle

Clinical trials at this site (9)

Search interface

LEvOsimendaN vs. Placebo Before Tricuspid VAlve Surgery in Patients with Right Ventricular Dysfunction Pending

2024-516167-86-00 Patients referred for an isolated or a combined surgica 5
HF-POLARIS: A research study to look at how well NNC0487-0111 works compared to placebo in people with heart failure and obesity Recruiting

2025-523717-29-00 HFpEF or HFmrEF and obesity 5 2026-04-28
DIAMOND Study - DIrect oral anticoagulant for Antithrombotic Management Of aortic bioprothesis implanted patients for valvular heart Disease… Recruiting

2024-516643-64-00 Aortic bioprothesis implanted patient for valvular hear 5 2026-03-13
EASi-PROTKT™ - A study to test vicadrostat (BI 690517) taken together with empagliflozin in people with type 2 diabetes, high blood pressure… Recruiting

2025-521188-11-00 Type 2 diabetes 5 2025-10-15
Phase III study to evaluate the effect of balcinrenone/dapagliflozin in patients with heart failure and impaired kidney function Recruiting

2023-508162-15-00 Chronic HF and comorbid impairment of kidney function w 5 2024-07-12
Open-label Extension Study to Evaluate the Long-term Safety and Tolerability of Aficamten (CK-3773274) in Adults With Hypertrophic Cardiomyo… Recruiting

2023-508963-58-00 Symptomatic hypertrophic cardiomyopathy (HCM) 4 2022-01-31
Selatogrel Outcome Study in Suspected Acute Myocardial Infarction Recruiting

2023-505438-85-00 Acute myocardial infarction (AMI) 5 2022-01-12
A study of aficamten (CK-3773274) in adults with symptomatic non-obstructive hypertrophic cardiomyopathy (ACACIA) Ended

2023-505797-15-00 SYMPTOMATIC NON-OBSTRUCTIVE HYPERTROPHIC CARDIOMYOPATHY 5 2024-09-13
ARTEMIS: A Phase 3 Study of Ravulizumab to Protect Patients with Chronic Kidney Disease (CKD) from Cardiac Surgery Associated Acute Kidney … Ended

2022-501802-36-00 Prevention of cardiac surgery associated acute kidney i 5 2023-06-16